According to BridgeBio Pharma 's latest financial reports the company's current revenue (TTM) is $0.21 B. In 2022 the company made a revenue of $77.64 M an increase over the years 2021 revenue that were of $69.71 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $9.3 M | -88.02% |
2022 | $77.64 M | 11.38% |
2021 | $69.71 M | 745.14% |
2020 | $8.24 M | -79.66% |
2019 | $40.56 M | |
2018 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 295.02% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.90% | ๐บ๐ธ USA |